sivelestat has been researched along with Hemorrhagic Shock in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akagi, R; Inoue, K; Maeshima, K; Morimatsu, H; Morita, K; Omori, E; Shimizu, H; Takahashi, T; Takeuchi, M; Toda, Y | 1 |
Binder, BR; Kushimoto, S; Okabe, H; Okajima, K | 1 |
2 other study(ies) available for sivelestat and Hemorrhagic Shock
Article | Year |
---|---|
A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats.
Topics: Animals; DNA; Gene Expression Regulation; Glycine; Intercellular Adhesion Molecule-1; Leukocyte Elastase; Lung; Lung Injury; Male; NF-kappa B; Nitric Oxide Synthase Type II; Organ Size; Protein Binding; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic; Sulfonamides; Tumor Necrosis Factor-alpha | 2007 |
Role of granulocyte elastase in the formation of hemorrhagic shock-induced gastric mucosal lesions in the rat.
Topics: Animals; Cells, Cultured; Endothelium, Vascular; Gastric Mucosa; Glycine; Humans; Leukocyte Elastase; Male; Pancreatic Elastase; Phlebotomy; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Shock, Hemorrhagic; Stomach Ulcer; Sulfonamides | 1996 |